Company Search:
Advanced Search
Sponsored Links
Prothena Corporation PLC Company Snapshot
Prothena Corporation PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Prothena Corporation PLC with three other companies in this sector in UNITED STATES : Capricor Therapeutics Inc (2019 sales of $1.01 million ), Lumos Pharma Inc ($936,000.00 of which 100% was biopharmaceutical segment), and Celsion Corporation ($500,000.00 ).

Sales Analysis. During the year ended December of 2019, sales at Prothena Corporation PLC were $814,000.00 . This is a decrease of 14.8% versus 2018, when the company's sales were $955,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Prothena Corporation PLC
  Stock Performance Chart for Prothena Corporation PLC
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 10.66
(Figures in U.S. Dollars)
1 Week -12.8%   13 Weeks -18.3%  
4 Weeks 7.6%   52 Weeks 27.4%  
Prothena Corporation PLC Key Data:
  Ticker: PRTA Country: Ireland
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 814,000
(Year Ending Jan 2020).
Employees: 51
  Currency: U.S. Dollars Market Cap: 425,455,663
  Fiscal Yr Ends: December Shares Outstanding: 39,911,413
  Share Type: Common Closely Held Shares: 11,663
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.